Cambrex opens new generic API manufacturing facility

Small molecule company Cambrex has opened a new quality control (QC) laboratory at its site in Paullo, Milan, Italy.

The laboratory expands on the current QC facilities that analyse and test Cambrex’s generic API portfolio of products during development and manufacturing.

It’s hoped that additional laboratory space will increase the efficiency of the QC department as the site expands the number of generic APIs in development. The laboratory includes news instruments such as a polarimeter and infrared spectrometer, and the systems have been linked to secure electronic data capturing software to allow full traceability.

“Our facility in Milan is the centre of the Cambrex’s generic API business, and this investment is the latest in a number of steps we have taken at the site to increase its efficiency and flexibility as we look to grow the portfolio of products that we offer,” commented Aldo Magnini, managing director, Cambrex Milan. “In the last year the company has made strategic investments to expand its capabilities in research and development, manufacturing, and now QC capabilities, as we look to take advantage of the opportunities that are arising in the generic market.”